Adults 18 to 90, any sex, with Hearing Loss. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Subjective Questionnaire of ComfortPrimary· Two weeks after fitting device A in right ear/device B in left ear (Day 14 of study), and two weeks after fitting device A in left ear/device B in right ear (Day 28 of study-final appointment)
Subjective ratings of comfort of each device in the ear, on a scale from 0 (very comfortable) to 10 (very uncomfortable/painful). No statistical analysis was planned for this measure.
Comfort Rating of Device A
Group
Value
95% CI
Intervention
0
0 – 7
Comfort Rating of Device B (investigational device)
Group
Value
95% CI
Intervention
0
0 – 10
Subjective Ratings of Occlusion With Both DevicesPrimary· Two weeks after fitting device A in right ear/device B in left ear (Day 14 of study), and two weeks after fitting device A in left ear/device B in right ear (Day 28 of study-final appointment)
Subjective ratings on how plugged participants' ears felt with each device in ear,on scale from 0 (not at all) to 10 (extremely plugged/cannot tolerate)
Occlusion Rating with Device A
Group
Value
95% CI
Intervention
0
0 – 8
Occlusion Rating with Device B (fitting modification)
Group
Value
95% CI
Intervention
0
0 – 10
Sponsor's own description
Evaluating the efficacy and effectiveness of an advancement in the fitting characteristics of extended wear technology with the commercially available device as a comparator.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07176936 — Improving Speech in Noise Using Noninvasive Stimulation
· NA
· recruiting
NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene
· NA
· recruiting
NCT07218913 — Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III
· Phase 1
· recruiting
NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit
· NA
· recruiting
NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
· NA
· recruiting
Other Sonova AG trials
Trials by the same sponsor.
NCT07526428 — Investigating the DNN Noise Reduction Feature in Phonak Hearing Aids Using Ecological Momentary Assessment
· NA
· enrolling by invitation
NCT07501312 — Remote Microphone Performance Comparison in Adults With Hearing Loss
· NA
· enrolling by invitation
NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit
· NA
· recruiting
NCT06957730 — A Comparison of Hearing Aid Noise Programs on Speech Intelligibility
· NA
· completed
NCT06746038 — Evaluation of Extended Wear Hearing Aid for Mild Hearing Loss
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sonova AG
Last refreshed: 14 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04882800.